http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201910347-T4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-302
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-94
filingDate 2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b21058a9fff7e00095cbd2c597351d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c661d2fd7427b0e8e298c2d9b0ecea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd6417d81bbb8063f1d923b14b34c4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e416f26e9cce0a57049f533d4a789a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeba25f81f75c5f07cd37c6f4d996465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b52c8245a23848e8082a3b97faf5e66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1fff95ff24c2ecf9ae1f3fb2a6566ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a589654bed30c6370786cc5bdbd54edc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4a97fdf0beb2375d1d013c0141c9523
publicationDate 2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-201910347-T4
titleOfInvention Antibodies to olanzapine haptens and their use.
abstract For example, an antibody that binds to olanzapine that can be used for the determination of olanzapine in a sample in a competitive immunoassay method is disclosed. The antibody can be used in a lateral flow analyzer for bedside olanzapine determination, including multiple determinations of aripiprazole, olanzapine, quetiapine and risperidone in a single lateral flow analyzer.
priorityDate 2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710

Total number of triples: 37.